Dr. Stefan Gross

Thursday, November 2, 2017
Agios Pharmaceuticals
Director, Enzymology

"Treatment of Rare Genetic Diseases by Small Molecule Allosteric Activators"

11:30 a.m.
LSL S330/340
Host: 
Mike Knapp